RYTHM (RYM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 11, 2025, to elect seven directors, ratify the appointment of GuzmanGray as auditor, and approve an amendment to the 2022 Omnibus Equity Incentive Plan to increase available shares by 250,000.
Only shareholders of record as of April 22, 2025, are entitled to vote; 1,952,014 shares of Common Stock were outstanding as of that date.
Voting can be done online, by phone, or by mail, and shareholders may participate virtually.
Voting matters and shareholder proposals
Proposals include electing seven directors for one-year terms, ratifying GuzmanGray as auditor for 2025, and amending the 2022 Omnibus Equity Incentive Plan.
Board recommends voting FOR all proposals.
No other business or shareholder proposals are scheduled for the meeting.
Board of directors and corporate governance
Board consists of seven members, with a majority deemed independent under Nasdaq standards.
Three standing committees: Audit, Compensation, and Nominating and Corporate Governance, all composed of independent directors.
Board held 20 meetings in 2024; all directors except two attended at least 75% of meetings.
Director nomination process considers experience, diversity, independence, and shareholder recommendations.
Chairman and CEO roles are currently combined, with rationale provided for this structure.
Latest events from RYTHM
- Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025 - Key votes include director elections, reverse stock split, and equity plan expansion.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and major equity plan amendments.RYM
Proxy Filing1 Dec 2025 - Quorum for the August 2024 Annual Meeting is now one-third of outstanding shares.RYM
Proxy Filing1 Dec 2025 - Equity line offering seeks up to $15M amid financial challenges and industry risks.RYM
Registration Filing29 Nov 2025 - Registering 4.7M shares for resale to raise up to $15M amid ongoing losses and dilution risk.RYM
Registration Filing28 Nov 2025 - Q3 2025 revenue hit $4.0M, nearly doubling sequentially as THC beverages expanded in retail.RYM
Q3 20257 Nov 2025